anxiety and semaglutide People with pre-existing depression or were less likely to have mental health worsening while taking a GLP-1 medication, observational Swedish data suggested. https://www.medpagetoday.com/psychiatry/generalpsychiatry/120515 Can switching a patient from

J Diabetes 2016;8:753765.ArticlePubMed 82

However, medical supervision is essential to evaluate risks, personalize treatment, and monitor long-term outcomes

Following the transplantation, diabetes control can be a challenge because of immunosuppression and glucocorticoid treatment

In 2021, the Food and Drug Administration (FDA) approved the brand-name version of semaglutide, Wegovy, for chronic weight management in adults with obesity or overweight

Standard protocol: begin semaglutide at 0.25 mg weekly, titrate to 1.02.4 mg over 1220 weeks (standard dose escalation), then add sermorelin once GI symptoms stabilise and appetite suppression plateaus